METiS TechBio (7666.HK) signed an exclusive global licensing agreement with US biotechnology firm Boulevard Bio, gaining rights to a trispecific T-cell engager targeting oncology indications.
After weeks of negotiating with the Trump administration, Anthropic is finally going to be able to bring Claude Fable 5 back ...
Anthropic's new Claude Sonnet 5 delivers near-flagship AI performance at 60% lower cost, targeting enterprise adoption as the ...
METiS TechBio (7666.HK), a leading AI-driven drug delivery innovation company, today announced it has entered into an ...
The Philippines' Technology News Blog Website, Sharing Specs and Beyond to Help Build a Tech-Informed, Tech-Empowered Nation.
Since 2017, Iason Gabriel has worked at the tech giant, trying to anticipate – and think through – the impact of AI. But as commercial and geopolitical pressures escalate, can ethicists make any ...
Aerospace and Mechanical Insider on MSN
Engineering trust through responsible AI governance
Artificial intelligence has become a central driver of innovation across sectors, from aerospace design optimization to ...
AI job displacement reached a new threshold in May 2026: for the third consecutive month, artificial intelligence was the leading reason U.S. employers cited for cutting positions, accounting for ...
Marketing AI agents as digital employees may make human workers worse at spotting errors and more likely to offload ...
Industry asks if it knows enough to move. Academia asks how it knows. AI just made both instincts essential—and put the ...
Claude AI robotics benchmark shows Opus 4.7 finishing physical robot programming in 9 minutes, against 181 minutes for ...
The number of U.S. data centers is growing, largely to power artificial intelligence programs. That has led to concern about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results